Angana Biswas
Kharagpur, WB 721302, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Targeting of HSP27 and MMP-2/9 Crosstalk by High-Throughput Drug Repurposing Strategies Identifies Paroxetine as a Potential Candidate in Glioblastoma.
Journal: Journal of medicinal chemistry
Published: February 16, 2026
PSMC2 promotes resistance against temozolomide in glioblastoma via suppressing JNK-mediated autophagic cell death.
Journal: Biochemical pharmacology
Published: September 26, 2024
Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene transformations in glioblastoma.
Journal: Cancer letters
Published: April 21, 2022
TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation.
Journal: Experimental cell research
Published: March 01, 2022
An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: February 10, 2022
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 16, 2020
ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: May 04, 2020
Transcriptional regulation of HSPB1 by Friend leukemia integration-1 factor modulates radiation and temozolomide resistance in glioblastoma.
Journal: Oncotarget
Published: November 11, 2019
Delineation of crosstalk between HSP27 and MMP-2/MMP-9: A synergistic therapeutic avenue for glioblastoma management.
Journal: Biochimica et biophysica acta. General subjects
Published: February 28, 2019
Targeting NFE2L2, a transcription factor upstream of MMP-2: A potential therapeutic strategy for temozolomide resistant glioblastoma.
Journal: Biochemical pharmacology
Published: January 26, 2019
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
Journal: Oncogene
Published: October 31, 2017
Glioma progression through the prism of heat shock protein mediated extracellular matrix remodeling and epithelial to mesenchymal transition.
Journal: Experimental cell research
Published: July 03, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026